Cannabis Commercialization as a Modifiable Public Health Exposure
This Viewpoint describes how policies shaping cannabis commercialization constitute a modifiable exposure and, thus, may influence psychiatric risk and suggests mitigation strategies.
Authors
- Andrew S. Hyatt (ORCID: https://orcid.org/0000-0003-1135-6195)
- Jodi M. Gilman (ORCID: https://orcid.org/0000-0001-5180-6694)
- Cheryl Y. S. Foo
- A. Eden Evins
Institutions
- Cambridge Health Alliance (US)
- Harvard University (US)
- Massachusetts General Hospital (US)
Publication Details
- Journal
- JAMA Psychiatry
- Published
- 2026-09-16
- DOI
- https://doi.org/10.1001/jamapsychiatry.2026.2869
- Primary Topic
- Cannabis and Cannabinoid Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00